Trial Profile
Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept Injection (ELYSIAN)
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- Acronyms ELYSIAN
- 18 Dec 2015 New trial record